NextCure, Inc.NXTCNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank88
5Y CAGR-14.2%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-14.2%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202517.71%
202411.68%
202316.35%
2022-7.20%
2021-89.00%
202038.15%
2019-114.15%
2018-47.39%
20170.00%